site background
Skip to content
Ivy Brain Tumor Center
Trial EligibilityDonate
Main Menu
  • Physicians
  • Industry
  • Ivy Blog
Talk to an Ivy Navigator
  • The Challenge
    • Current Standard of Care
    • Conventional Clinical Trials
  • Phase 0 Clinical Trials
    • What is a Phase 0 Trial?
    • Why Phase 0 Trials?
    • What We Treat
      • Gliomas
      • Brain Metastases
      • Meningiomas
      • Ependymomas
      • Craniopharyngiomas
      • Pineal-Region Tumors
    • Current Trials
  • Patients
    • Patient Stories
    • What to Expect
    • Planning Your Visit
      • Lodging
      • Transportation
    • Patient Support
    • FAQs
    • Share Your Story
  • Research
    • Scientific Cores
    • Labs
      • Mehta Laboratory
      • Tovmasyan Laboratory
      • Tien Laboratory
      • Mirzadeh Laboratory
    • Certifications
    • Preclinical Work
    • Industry Collaboration
    • Published Research
  • About
    • Team
      • Administration
      • Business Operations
      • Clinical Operations
      • Communications
      • Preclinical and Translational Science
    • Barrow Neurological Institute
    • The Ben and Catherine Ivy Foundation
    • Newsroom
    • Events
    • Support
    • Careers
    • Contact Us
  • #Itspersonal

Talk to an Ivy Navigator

602-406-8605
Despite COVID-19, our ongoing trials remain open for enrollment and new trials are launching now.
Zaman Mirzadeh, MD, PhD
Zaman Mirzadeh
  • phone:(602) 406-7776
  • Send Email

Zaman Mirzadeh, MD, PhD

Metabolism Core Leader

Dr. Zaman Mirzadeh earned his doctorate and medical degrees from the University of California at San Francisco. He completed his residency at the Barrow Neurological Institute in Phoenix, Arizona, and fellowships in functional neurosurgery at the Toronto Western Hospital in Toronto, Ontario and Baylor College of Medicine/MD Anderson Cancer Center in Houston, Texas.  Dr. Mirzadeh’s research interests include stem cell biology and metabolic modulation. His laboratory focuses on understanding the relationship between endogenous CNS progenitor elements and human pathologies. As a Principal Investigator within the Ivy Brain Tumor Center, his expertise in cellular biology and stem cell biology are key drivers of our Phase 0 clinical trials program.

Arial shot of the Ivy Brain Tumor Center
Ivy Brain Tumor Center
  • The Challenge
    • Current Standard of Care
    • Conventional Clinical Trials
  • Phase 0 Clinical Trials
    • Why Phase 0 Trials?
    • What We Treat
    • Current Trials
  • Patients
    • Patient Stories
    • What to Expect
    • Planning Your Visit
    • Patient Support
    • FAQs
  • About
    • Team
    • Barrow Neurological Institute
    • The Ben and Catherine Ivy Foundation
    • Newsroom
    • Events
    • Support
    • Careers
    • Contact Us

Stay Updated

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

2910 North Third Avenue
Phoenix, Arizona 85013
(602) 406-6489
[email protected]
Mailing Address for Donations »

© Ivy Brain Tumor Center, 2021. All Rights Reserved.
  • Privacy Policy
  • Site Map
Important Notice

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device.